| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0 | 0.97 | Catechol O-methyltransferase inhibitor | 0.938 0 DBMET03236 0.936 0 DBMET03237 0.953 0 DBMET03238 0.602 0.001 DBMET03239 0.392 0.001 DBMET03240 0.846 0.001 DBMET03241 | ||
| 0.416 | 0.04 | 0.464 | Caspase 3 stimulant | 0.435 0.034 DBMET03237 0.432 0.035 DBMET03238 0.452 0.029 DBMET03239 0.464 0.026 DBMET03240 0.399 0.045 DBMET03241 | DBMET03240 | |
| 0.341 | 0.05 | 0.453 | Aryl hydrocarbon receptor agonist | 0.394 0.038 DBMET03237 0.382 0.041 DBMET03238 0.407 0.036 DBMET03239 0.453 0.029 DBMET03240 | DBMET03240 | |
| 0.27 | 0.013 | 0.27 | Glutamate receptor antagonist | 0.229 0.019 DBMET03236 0.216 0.022 DBMET03237 0.214 0.022 DBMET03238 0.134 0.062 DBMET03239 | ||
| 0.218 | 0.009 | 0.246 | Sphingosine 1-phosphate receptor 2 agonist | 0.144 0.03 DBMET03236 0.197 0.012 DBMET03237 0.209 0.01 DBMET03238 0.246 0.007 DBMET03239 0.233 0.008 DBMET03240 0.119 0.056 DBMET03241 | DBMET03239 | |
| 0.205 | 0.006 | 0.235 | DOPA decarboxylase inhibitor | 0.094 0.088 DBMET03236 0.151 0.021 DBMET03237 0.152 0.02 DBMET03238 0.235 0.004 DBMET03239 0.175 0.012 DBMET03240 | DBMET03239 | |
| 0.24 | 0.064 | 0.288 | Pyruvate kinase inhibitor | 0.261 0.058 DBMET03237 0.209 0.076 DBMET03238 0.288 0.051 DBMET03239 0.25 0.061 DBMET03240 | DBMET03239 | |
| 0.173 | 0.017 | 0.173 | Sphingosine 1-phosphate receptor 4 antagonist | 0.159 0.026 DBMET03237 0.166 0.021 DBMET03238 0.169 0.02 DBMET03239 0.161 0.024 DBMET03240 | ||
| 0.193 | 0.06 | 0.208 | Mcl-1 antagonist | 0.134 0.108 DBMET03237 0.147 0.093 DBMET03238 0.208 0.052 DBMET03239 0.156 0.084 DBMET03240 | DBMET03239 | |
| 0.142 | 0.01 | 0.203 | Sphingosine 1-phosphate receptor 4 agonist | 0.104 0.023 DBMET03237 0.114 0.019 DBMET03238 0.203 0.004 DBMET03239 0.17 0.006 DBMET03240 | DBMET03239 | |
| 0.112 | 0.005 | 0.126 | Sphingosine 1-phosphate receptor 3 agonist | 0.065 0.01 DBMET03236 0.091 0.007 DBMET03237 0.092 0.007 DBMET03238 0.126 0.005 DBMET03239 0.105 0.006 DBMET03240 0.046 0.018 DBMET03241 | DBMET03239 | |
| 0.091 | 0.01 | 0.102 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET03236 0.074 0.015 DBMET03237 0.077 0.014 DBMET03238 0.102 0.008 DBMET03239 0.086 0.011 DBMET03240 0.052 0.042 DBMET03241 | DBMET03239 | |
| 0.143 | 0.082 | 0.242 | Heat shock protein 90 antagonist | 0.147 0.078 DBMET03238 0.237 0.025 DBMET03239 0.242 0.023 DBMET03240 | DBMET03240 | |
| 0.065 | 0.011 | 0.065 | Benzodiazepine inverse agonist | 0.047 0.032 DBMET03236 0.061 0.014 DBMET03237 0.062 0.013 DBMET03238 0.063 0.013 DBMET03239 0.061 0.014 DBMET03240 | ||
| 0.142 | 0.095 | 0.231 | Heat shock protein 90 alpha antagonist | 0.142 0.096 DBMET03237 0.131 0.109 DBMET03238 0.231 0.034 DBMET03239 0.217 0.04 DBMET03240 | DBMET03239 | |
| 0.132 | 0.097 | 0.158 | Sphingosine 1-phosphate receptor 5 antagonist | 0.158 0.048 DBMET03239 | DBMET03239 | |
| 0.043 | 0.009 | 0.051 | Carnitine palmitoyltransferase 1A inhibitor | 0.029 0.019 DBMET03236 0.051 0.007 DBMET03237 0.043 0.009 DBMET03238 0.05 0.007 DBMET03239 0.05 0.007 DBMET03240 0.026 0.025 DBMET03241 | DBMET03237 | |
| 0.174 | 0.142 | 0.174 | Nitric-oxide synthase stimulant | 0.171 0.151 DBMET03237 0.166 0.164 DBMET03238 0.173 0.146 DBMET03241 | ||
| 0.043 | 0.017 | 0.044 | CF transmembrane conductance regulator antagonist | 0.044 0.016 DBMET03239 | DBMET03239 | |
| 0.121 | 0.101 | 0.136 | Farnesoid X receptor antagonist | 0.119 0.106 DBMET03237 0.136 0.072 DBMET03239 0.126 0.09 DBMET03240 | DBMET03239 | |
| 0.074 | 0.059 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.081 0.043 DBMET03239 | DBMET03239 | |
| 0.103 | 0.088 | 0.124 | M18 aspartyl aminopeptidase inhibitor | 0.1 0.091 DBMET03237 0.124 0.067 DBMET03239 | DBMET03239 | |
| 0.203 | 0.195 | 0.418 | Immunosuppressant | 0.228 0.168 DBMET03237 0.231 0.165 DBMET03239 0.222 0.174 DBMET03240 0.418 0.056 DBMET03241 | DBMET03241 | |
| 0.116 | 0.113 | 0.273 | Cholinergic | 0.129 0.097 DBMET03237 0.131 0.094 DBMET03238 0.269 0.024 DBMET03239 0.273 0.023 DBMET03240 | DBMET03240 | |
| 0.048 | 0.06 | 0.088 | Glutamate (mGluR) agonist | 0.088 0.027 DBMET03239 0.066 0.039 DBMET03240 | DBMET03239 | |
| 0.057 | 0.073 | 0.081 | Glutamate (mGluR group I) antagonist | 0.081 0.037 DBMET03239 0.07 0.048 DBMET03240 | DBMET03239 | |
| 0.034 | 0.053 | 0.059 | Glutamate (mGluR5) antagonist | 0.059 0.023 DBMET03239 0.049 0.03 DBMET03240 | DBMET03239 | |
| 0.13 | 0.176 | 0.367 | Free radical scavenger | 0.367 0.035 DBMET03241 | DBMET03241 | |
| 0.047 | 0.109 | 0.074 | Glutamate (mGluR) antagonist | 0.074 0.056 DBMET03239 | DBMET03239 | |
| 0.065 | 0.131 | 0.095 | Thioredoxin inhibitor | 0.095 0.054 DBMET03241 | DBMET03241 | |
| 0.036 | 0.11 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 DBMET03236 | DBMET03236 | |
| 0.054 | 0.132 | 0.094 | 5-Lipoxygenase inhibitor | 0.094 0.069 DBMET03237 | DBMET03237 | |
| 0.113 | 0.224 | 0.381 | Antioxidant | 0.185 0.128 DBMET03236 0.381 0.038 DBMET03241 | DBMET03241 | |
| 0.07 | 0.182 | 0.112 | Electron transport complex I inhibitor | 0.102 0.077 DBMET03238 0.112 0.06 DBMET03240 | DBMET03240 | |
| 0.027 | 0.144 | 0.06 | Nitric oxide donor | 0.06 0.049 DBMET03241 | DBMET03241 | |
| 0.019 | 0.17 | 0.092 | HIV-1 integrase (Strand Transfer) inhibitor | 0.092 0.026 DBMET03236 | DBMET03236 | |
| 0.066 | 0.221 | 0.202 | Protein-tyrosine phosphatase inhibitor | 0.202 0.046 DBMET03236 | DBMET03236 | |
| 0.055 | 0.21 | 0.168 | Lipid peroxidase inhibitor | 0.168 0.057 DBMET03241 | DBMET03241 | |
| 0.067 | 0.24 | 0.224 | Dual specificity phosphatase 3 inhibitor | 0.224 0.05 DBMET03236 | DBMET03236 | |
| 0.122 | 0.299 | 0.366 | Alpha-glucosidase inhibitor | 0.229 0.2 DBMET03239 0.226 0.202 DBMET03240 0.366 0.129 DBMET03241 | DBMET03241 | |
| 0.097 | 0.297 | 0.191 | Thioredoxin glutathione reductase inhibitor | 0.19 0.181 DBMET03239 0.191 0.18 DBMET03240 | DBMET03240 | |
| 0.163 | 0.386 | 0.278 | Caspase 9 stimulant | 0.278 0.219 DBMET03240 | DBMET03240 | |
| 0.058 | 0.283 | 0.173 | Cell wall synthesis inhibitor | 0.173 0.045 DBMET03236 0.168 0.049 DBMET03241 | DBMET03236 | |
| 0.06 | 0.286 | 0.195 | Dual specificity phosphatase inhibitor | 0.195 0.057 DBMET03236 | DBMET03236 | |
| 0.097 | 0.339 | 0.294 | DNA polymerase beta inhibitor | 0.29 0.171 DBMET03239 0.294 0.168 DBMET03240 | DBMET03240 | |
| 0.034 | 0.32 | 0.146 | Multidrug resistance-associated protein 1 inhibitor | 0.146 0.027 DBMET03236 0.097 0.084 DBMET03240 | DBMET03236 | |
| 0.033 | 0.324 | 0.102 | Beta glucuronidase inhibitor | 0.102 0.067 DBMET03241 | DBMET03241 | |
| 0.053 | 0.347 | 0.219 | Nitric oxide antagonist | 0.219 0.061 DBMET03241 | DBMET03241 | |
| 0.059 | 0.359 | 0.146 | NOS3 expression enhancer | 0.146 0.076 DBMET03241 | DBMET03241 | |
| 0.008 | 0.31 | 0.032 | NMDA 2D receptor antagonist | 0.032 0.014 DBMET03236 | DBMET03236 | |
| 0.086 | 0.406 | 0.244 | Transcription factor inhibitor | 0.218 0.211 DBMET03239 0.244 0.191 DBMET03240 | DBMET03240 | |
| 0.07 | 0.403 | 0.275 | DNA directed DNA polymerase inhibitor | 0.275 0.176 DBMET03239 0.264 0.183 DBMET03240 | DBMET03239 | |
| 0.108 | 0.449 | 0.358 | Apoptosis agonist | 0.358 0.135 DBMET03241 | DBMET03241 | |
| 0.05 | 0.407 | 0.186 | Vasodilator | 0.186 0.117 DBMET03241 | DBMET03241 | |
| 0.055 | 0.427 | 0.235 | Thyroid hormone beta antagonist | 0.209 0.147 DBMET03239 0.235 0.128 DBMET03240 | DBMET03240 | |
| 0.053 | 0.433 | 0.233 | Thyroid hormone antagonist | 0.214 0.149 DBMET03239 0.233 0.135 DBMET03240 | DBMET03240 | |
| 0.005 | 0.432 | 0.076 | Antineoplastic antibiotic | 0.076 0.06 DBMET03241 | DBMET03241 | |
| 0.051 | 0.55 | 0.503 | Antibacterial | 0.503 0.04 DBMET03241 | DBMET03241 | |
| 0.064 | 0.588 | 0.269 | Apoptosis antagonist | 0.269 0.109 DBMET03241 | DBMET03241 | |
| 0.08 | 0.606 | 0.291 | Peptidyltransferase inhibitor | 0.291 0.028 DBMET03241 | DBMET03241 | |
| 0.045 | 0.579 | 0.358 | Hypoglycemic | 0.358 0.036 DBMET03241 | DBMET03241 | |
| 0.035 | 0.604 | 0.24 | Hepatoprotectant | 0.24 0.046 DBMET03241 | DBMET03241 | |
| 0.022 | 0.629 | 0.093 | Toll-Like receptor 4 antagonist | 0.093 0.082 DBMET03241 | DBMET03241 | |
| 0.004 | 0.641 | 0.062 | NMDA 2B receptor antagonist | 0.062 0.029 DBMET03236 | DBMET03236 | |
| 0.003 | 0.699 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET03236 | DBMET03236 | |
| 0.056 | 0.77 | 0.278 | Interleukin 2 agonist | 0.278 0.091 DBMET03241 | DBMET03241 | |
| 0.01 | 0.741 | 0.149 | Thrombolytic | 0.149 0.083 DBMET03241 | DBMET03241 | |
| 0.004 | 0.774 | 0.169 | Selectin antagonist | 0.169 0.015 DBMET03241 | DBMET03241 | |
| 0.01 | 0.807 | 0.37 | Angiogenesis stimulant | 0.148 0.124 DBMET03236 0.37 0.028 DBMET03241 | DBMET03241 | |
| 0.006 | 0.837 | 0.055 | Protein 50S ribosomal subunit inhibitor | 0.055 0.035 DBMET03241 | DBMET03241 | |
| 0.006 | 0.877 | 0.047 | Antibiotic Aminoglycoside-like | 0.047 0.015 DBMET03241 | DBMET03241 | |
| 0.007 | 0.932 | 0.271 | Antiinflammatory | 0.271 0.245 DBMET03241 | DBMET03241 | |
| 0.005 | 0.938 | 0.319 | Cyclophilin D inhibitor | 0.319 0.146 DBMET03241 | DBMET03241 | |
| 0.004 | 0.951 | 0.145 | Anticoagulant | 0.145 0.085 DBMET03236 | DBMET03236 | |
| 0.001 | 0.987 | 0.109 | Cholecystokinin A agonist | 0.109 0.004 DBMET03236 | DBMET03236 | |
| 0.001 | 0.99 | 0.111 | Cholecystokinin agonist | 0.111 0.004 DBMET03236 | DBMET03236 | |
| 0.003 | 0.993 | 0.25 | Cholecystokinin B agonist | 0.25 0.004 DBMET03236 | DBMET03236 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |